The Scientist and the Scientist

The Scientist has been in print for more than 11 years now--this is the 279th consecutive issue. During that time it has evolved through various stages guided by its founder and publisher, Eugene Garfield, who has brought it to its present position as a respected and established source of news and information for the life sciences professional. Recently, it was a great honor and challenge to me to assume the role of publisher. It is my primary goal and responsibility to guide The Scientist thr

Written byAlexander Grimwade
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Scientist has been in print for more than 11 years now--this is the 279th consecutive issue. During that time it has evolved through various stages guided by its founder and publisher, Eugene Garfield, who has brought it to its present position as a respected and established source of news and information for the life sciences professional. Recently, it was a great honor and challenge to me to assume the role of publisher. It is my primary goal and responsibility to guide The Scientist through its second decade and beyond.

The world of science publishing is undergoing momentous changes, with the development, after decades of promises and false starts, of a viable means of electronic publication through the Internet. The Scientist is proud to have been one of the first journals to appear in full text form on the Internet. Our gopher version began with 1990 issues. Subsequently, a World ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies